GroupLevinson Public Relations Press Releases - EIN Presswire

Published on October 3, 2022 - 15:27 GMT

Thought Leader, Tony Mannino: Does Your Company Really Need Transformation To Grow?

C-Suite Thought Leader On Scaling vs. Transformation To Grow Your Business PHILADELPHIA, PA, USA, October 3, 2022 /⁨EINPresswire.com⁩/ -- FOR IMMEDIATE RELEASE & INTERVIEW: C-SUITE THOUGHT LEADER: DOES YOUR COMPANY REALLY NEED TRANSFORMATION TO …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 3, 2022 - 15:20 GMT

PAINWeek Conference Panel Answers: "What's Next To Combat The Prescription Drug Crisis?"

Conference Panel Defines The Qualities Of An Ideal Analgesic. Ensysce Biosciences (NASDAQ:ENSC) LAS VEGAS, NV, USA, October 3, 2022 /⁨EINPresswire.com⁩/ -- The world is experiencing a crisis in pain management and prescription drug abuse. Over the last …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on September 1, 2022 - 13:00 GMT

BREAKING NEWS: Gentell To Become One of N. America's Largest Wound Care Dressing Mfg. With Acquisition From Integra

David Navazio, President & CEO of Gentell announces the purchase of certain traditional and advanced wound care products & dressings from Integra LifeSciences PHILADELPHIA, PA, USA, September 1, 2022 /⁨EINPresswire.com⁩/ -- GENTELL ACQUIRES …

Distribution channels: Business & Economy, Emergency Services ...

Published on August 26, 2022 - 06:31 GMT

THOUGHT LEADER TONY MANNINO: 7 SCALING TIPS YOUR STARTUP NEEDS TO ADOPT FROM DAY ONE

Does your startup have a repeatable process that can be duplicated and multiplied without adding proportionately to costs? PHILADELPHIA, PENNSYLVANIA, UNITED STATES, August 26, 2022 /⁨EINPresswire.com⁩/ -- THOUGHT LEADER TONY MANNINO: 7 SCALING TIPS YOUR …

Distribution channels: Business & Economy, Companies ...

Published on August 16, 2022 - 13:45 GMT

THOUGHT LEADER, DR. LYNN KIRKPATRICK DISCUSSES A NEW CLASS OF PRESCRIPTION DRUGS DESIGNED TO DEFEAT ABUSE & OVERDOSE

Ensysce Biosciences (NASDAQ:ENSC) LA JOLLA, CA, USA, August 16, 2022 /⁨EINPresswire.com⁩/ -- The world is experiencing a crisis in prescription drug abuse and overdose. According to the NIH (National Institutes of Health), several types of prescription …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 31, 2022 - 15:42 GMT

4 Key Elements Influencing The Shape Of Learning & Development For The Enterprise

Thought Leader Suzanne McCall On The Future of L&D PHILADELPHIA, PA, USA, May 31, 2022 /⁨EINPresswire.com⁩/ -- Enterprise learning and development programs are undergoing transformative change as the business world emerges from the pandemic. …

Distribution channels: Business & Economy, Companies ...

Published on April 11, 2022 - 17:16 GMT

The Highly Novel Science Behind The Next Generation of Drugs Combatting Abuse and Overdose

Ensysce is in the process of developing a new class of powerful, tamper-proof prescription opioids that prevent both drug abuse and overdoses. Ensysce Biosciences, Inc. (NASDAQ:ENSC) LA JOLLA, CA, USA, April 11, 2022 /⁨EINPresswire.com⁩/ -- The world is …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on March 14, 2022 - 17:37 GMT

The Next Generation in Opioid Science and Pain Relief - Opioid 4.0

CEO Kirkpatrick: “NextGen will see innovation in pain relief where the chemistry in the drug itself will restrict abuse, like Ensysce's novel prodrug, PF614. Ensysce Biosciences, Inc. (NASDAQ:ENSC) LA JOLLA, CA, USA, March 14, 2022 /⁨EINPresswire.com …

Distribution channels: Healthcare & Pharmaceuticals Industry ...